In this series' last installment, I tackled the IP lessons learned in traditional startups. Here, I explore IP paint points experienced by some non-traditional companies, such as non-profit, non-tech, ...

Selin Sinem Erciyas of Gün + Partners suggests that intellectual property waivers and compulsory licensing are not the answer in developing and accessing vaccines, and explains why governments should ...

In the ten years or so that it has taken for design reuse, or design with IP, to go from a niche interest to mainstream chip implementation, teams have developed an understanding of what it can do for ...